Iohexol structure
|
Common Name | Iohexol | ||
---|---|---|---|---|
CAS Number | 66108-95-0 | Molecular Weight | 821.138 | |
Density | 2.2±0.1 g/cm3 | Boiling Point | 891.5±65.0 °C at 760 mmHg | |
Molecular Formula | C19H26I3N3O9 | Melting Point | 254-2560C | |
MSDS | Chinese USA | Flash Point | 493.0±34.3 °C |
Use of IohexolIohexol is a contrast agent.Target: OthersIohexol is a contrast agent. The osmolality of iohexol ranges from 322 mOsm/kg-approximately 1.1 times that of blood plasma-to 844 mOsm/kg, almost three times that of blood. Despite this difference, iohexol is still considered a low-osmolality contrast agent; the osmolality of older agents, such as diatrizoate, may be more than twice as high. From Wikipedia. |
Name | iohexol |
---|---|
Synonym | More Synonyms |
Description | Iohexol is a contrast agent.Target: OthersIohexol is a contrast agent. The osmolality of iohexol ranges from 322 mOsm/kg-approximately 1.1 times that of blood plasma-to 844 mOsm/kg, almost three times that of blood. Despite this difference, iohexol is still considered a low-osmolality contrast agent; the osmolality of older agents, such as diatrizoate, may be more than twice as high. From Wikipedia. |
---|---|
Related Catalog | |
References |
Density | 2.2±0.1 g/cm3 |
---|---|
Boiling Point | 891.5±65.0 °C at 760 mmHg |
Melting Point | 254-2560C |
Molecular Formula | C19H26I3N3O9 |
Molecular Weight | 821.138 |
Flash Point | 493.0±34.3 °C |
Exact Mass | 820.880310 |
PSA | 199.89000 |
LogP | -4.16 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.724 |
Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | S22-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 1 |
RTECS | CZ2205000 |
HS Code | 2924299090 |
~% Iohexol CAS#:66108-95-0 |
Literature: US4250113 A1, ; |
~% Iohexol CAS#:66108-95-0 |
Literature: US5847212 A1, ; |
~% Iohexol CAS#:66108-95-0 |
Literature: WO2007/60380 A1, ; Page/Page column 5-6 ; |
~% Iohexol CAS#:66108-95-0 |
Literature: US2011/21829 A1, ; Page/Page column 5 ; |
~7% Iohexol CAS#:66108-95-0 |
Literature: WO2011/63551 A1, ; Page/Page column 15-16 ; |
~% Iohexol CAS#:66108-95-0 |
Literature: US5965772 A1, ; |
~% Iohexol CAS#:66108-95-0 |
Literature: US5705692 A1, ; |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Construction of a biocompatible decellularized porcine hepatic lobe for liver bioengineering.
Int. J. Artif. Organs 38 , 96-104, (2015) One of the major obstacles in applying decellularized organs for clinical use is the recellularization step, during which huge numbers of cells are required to develop whole livers. We established a s... |
|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Chem. Res. Toxicol. 23 , 171-83, (2010) Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental... |
|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- |
5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide |
Exypaque |
1,3-benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- |
5-[acétyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzène-1,3-dicarboxamide |
Omnipaque |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- |
Iohexol |
MFCD00077732 |
UNII:4419T9MX03 |
Nycodenz |
omnipaqueTM |
5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodbenzol-1,3-dicarboxamid |
5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide |
5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide |
EINECS 266-164-2 |
Omnipaque 240 |
Iohexolum |